Extended Protective Shield Under Table to Reduce Operator Radiation Dose in Percutaneous Coronary Procedures.


Journal

Circulation. Cardiovascular interventions
ISSN: 1941-7632
Titre abrégé: Circ Cardiovasc Interv
Pays: United States
ID NLM: 101499602

Informations de publication

Date de publication:
02 2019
Historique:
entrez: 9 2 2019
pubmed: 9 2 2019
medline: 26 2 2020
Statut: ppublish

Résumé

Different tools and devices are effective to reduce operator radiation exposure at thorax level during percutaneous coronary procedures, but the operator radiation dose received at pelvic region still remains high. Our aim was to evaluate the efficacy of under-the-table adjunctive shields to reduce operator radiation exposure during percutaneous coronary procedures Methods and Results: The EXTRA-RAD study (Extended Protective Shield Under Table to Reduce Operator Radiation Dose in Percutaneous Coronary Procedures) is a prospective, single-center, randomized study. Patients who underwent transradial coronary procedures were randomized into 2 groups: group 1 (standard arrangement) and group 2 (adjunctive anti-rx shield under the angiographic table). In group 2, a further randomization was performed to compare 2 different under-the-table shields (a small curtain and a drape). A total of 205 procedures (122 diagnostic coronary angiographies and 83 percutaneous coronary interventions) performed in 157 patients by 4 different operators were included without significant differences in clinical and procedural characteristics between groups. The use of adjunctive shields was associated with lower radiation dose compared with no shield at pelvic region (42 µSv [14-98] in group 1, 13 µSv [5-27] in group 2; P<0.0001) and also at thorax level (4 µSv [1-13] in group 1, 2 µSv [1-4] in group 2; P=0.001). The reduction in dose was observed in all the operators. No significant differences were observed in pelvic dose using the 2 different shields ( P=0.183). The use of adjunctive anti-rx shields under the angiographic table during transradial coronary procedures is associated with a significant lower radiation dose to operators at pelvic and thorax level. URL: https://www.clinicaltrials.gov . Unique identifier: NCT03259126.

Sections du résumé

BACKGROUND
Different tools and devices are effective to reduce operator radiation exposure at thorax level during percutaneous coronary procedures, but the operator radiation dose received at pelvic region still remains high. Our aim was to evaluate the efficacy of under-the-table adjunctive shields to reduce operator radiation exposure during percutaneous coronary procedures Methods and Results: The EXTRA-RAD study (Extended Protective Shield Under Table to Reduce Operator Radiation Dose in Percutaneous Coronary Procedures) is a prospective, single-center, randomized study. Patients who underwent transradial coronary procedures were randomized into 2 groups: group 1 (standard arrangement) and group 2 (adjunctive anti-rx shield under the angiographic table). In group 2, a further randomization was performed to compare 2 different under-the-table shields (a small curtain and a drape). A total of 205 procedures (122 diagnostic coronary angiographies and 83 percutaneous coronary interventions) performed in 157 patients by 4 different operators were included without significant differences in clinical and procedural characteristics between groups. The use of adjunctive shields was associated with lower radiation dose compared with no shield at pelvic region (42 µSv [14-98] in group 1, 13 µSv [5-27] in group 2; P<0.0001) and also at thorax level (4 µSv [1-13] in group 1, 2 µSv [1-4] in group 2; P=0.001). The reduction in dose was observed in all the operators. No significant differences were observed in pelvic dose using the 2 different shields ( P=0.183).
CONCLUSIONS
The use of adjunctive anti-rx shields under the angiographic table during transradial coronary procedures is associated with a significant lower radiation dose to operators at pelvic and thorax level.
CLINICAL TRIAL REGISTRATION
URL: https://www.clinicaltrials.gov . Unique identifier: NCT03259126.

Identifiants

pubmed: 30732471
doi: 10.1161/CIRCINTERVENTIONS.118.007586
doi:

Banques de données

ClinicalTrials.gov
['NCT03259126']

Types de publication

Comparative Study Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

e007586

Auteurs

Alessandro Sciahbasi (A)

Interventional Cardiology, Sandro Pertini Hospital, Rome, Italy (A. Sciahbasi, S.R., R.P., M.C., C.D.R., S.F., G.F.).

Alessandro Sarandrea (A)

HSE Management, Rome, Italy (A.Sarandrea).

Stefano Rigattieri (S)

Interventional Cardiology, Sandro Pertini Hospital, Rome, Italy (A. Sciahbasi, S.R., R.P., M.C., C.D.R., S.F., G.F.).

Roberto Patrizi (R)

Interventional Cardiology, Sandro Pertini Hospital, Rome, Italy (A. Sciahbasi, S.R., R.P., M.C., C.D.R., S.F., G.F.).

Maria Cera (M)

Interventional Cardiology, Sandro Pertini Hospital, Rome, Italy (A. Sciahbasi, S.R., R.P., M.C., C.D.R., S.F., G.F.).

Cristian Di Russo (C)

Interventional Cardiology, Sandro Pertini Hospital, Rome, Italy (A. Sciahbasi, S.R., R.P., M.C., C.D.R., S.F., G.F.).

Luigi Zezza (L)

Institute of Life Sciences, Sant'Anna School of Advanced Studies, Pisa, Italy (L.Z.).

Silvio Fedele (S)

Interventional Cardiology, Sandro Pertini Hospital, Rome, Italy (A. Sciahbasi, S.R., R.P., M.C., C.D.R., S.F., G.F.).

Giuseppe Ferraiuolo (G)

Interventional Cardiology, Sandro Pertini Hospital, Rome, Italy (A. Sciahbasi, S.R., R.P., M.C., C.D.R., S.F., G.F.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH